Risk of Testosterone Injections

Testosterone injections consist of synthetic testosterone, which is used medically to treat hypogonadism. These injections can result in detrimental side effects, and patients suffering from certain pre-existing conditions should not take testosterone shots.

Identification

• The testes of human males produce testosterone, a hormone that plays an integral role in proper sexual development and sperm production. Testosterone also triggers anabolic (tissue-building) effects, increasing bone density and promoting muscle growth.

Benefits

• Doctors can prescribe pharmaceutical testosterone for patients suffering from hypogonadism, a condition that can result in lessened libido, erectile dysfunction, fatigue, memory and concentration problems, lower muscle mass and bone density, and deterioration in mental health and overall well-being. Regular injections of testosterone can alleviate these problems.

Warnings

• Patients with pre-existing prostate cancer or male breast cancer should not take testosterone injections. Also, those suffering from diabetes or who have a history of liver, heart or circulatory disease should consult their doctor before taking testosterone.

Dangers

• Testosterone use can result in peliosis hepatis, a sometimes fatal condition. Patients taking testosterone may also experience an alteration of blood serum cholesterol levels, which may cause clotting problems, arteriosclerosis, congestive heart failure and stroke. Some patients have reported allergic reactions ranging from rashes, swelling and hives to chest pain and labored breathing.

Masculinization

• Testosterone injections can increase masculine characteristics, including male pattern baldness, acne, oily skin, altered libido and excess facial and body hair. In some patients, testosterone has caused erectile dysfunction and the development of male breast tissue.

Complications

• Patients prescribed testosterone receive injections on a regular basis, which can lead to abscesses, infection and scar tissue.